MYC and cancer: The critical feature of c-MYC in many human cancers is its hyperactivity caused by chromosomal translocations or amplifications of the c-MYC gene leading to increased mRNA expression, or by an enhanced stability caused by mutations or constitutively active intracellular signaling pathways that activate c-MYC expression.